ConvaTec Introduces GentleCath™ Pro Closed-System Intermittent Catheter and GentleCath™ Insertion Kit
Closed-System “No-touch” catheterization helps minimize the risk of infection , with cath-anywhere convenience
LUXEMBOURG (October 20, 2015) — ConvaTec, a leading global medical products and technologies company, today launched the GentleCath™ Pro Closed-System Intermittent Catheter. GentleCath™ Pro features a collection bag and GentleCath™ Introducer Tip, which enables “no-touch” catheterization to help minimize the risk of infection1,2 while providing the convenience to use the catheter where and when it is needed.
Simultaneously, ConvaTec launched the GentleCath™ Insertion Kit, which includes all necessary catheter insertion supplies required by users to perform sterile technique intermittent catheterization.3
Intermittent catheter users are at increased risk of urinary tract infection caused by bacteria in the urine, which can come from the hands of a user touching the catheter prior to insertion4. The “no-touch” nature of GentleCath™ Pro Closed-System minimizes the risk of infection for patients who self-catheterize by helping to prevent the transfer of bacteria.1,2
The GentleCath™ Pro Closed-System’s collection bag allows the user to measure and monitor the amount of fluid drained, or simply to catheterize when a bathroom or toilet is not available or easily accessible. The Introducer Tip is designed to be inserted into the urethra and allow the catheter to pass through, helping it to avoid contact with bacteria that may build up at the entrance to the urethra5.
The GentleCath™ Insertion Kit includes an underpad, exam gloves, collection bag, non-staining antiseptic pad and lubricating jelly. This range of insertion supplies is designed to be used standalone or in combination to allow users to perform sterile technique intermittent catheterization in the way that works best for them.
“This joint launch adds to the extensive portfolio of GentleCath™ intermittent catheters, which now includes uncoated, red rubber, hydrophilic and closed-system catheters – all available with both straight and coudé tip options.” said Mads Haugaard, Vice President and General Manager, Continence and Critical Care. “We now provide a GentleCath™ product range that caters to all intermittent catheter users, helping them to minimize infection and delivering a comfortable insertion and removal experience.”
Currently, the GentleCath™ Pro Closed-System Intermittent Catheter is available in the U.S. only.
For more information, visit www.convatec.com or call ConvaTec customer service at 1-800-422-8811.
ConvaTec is a global medical products and technologies company, with leading market positions in wound therapeutics, ostomy care, continence and critical care, and infusion devices. Its products provide a range of clinical and economic benefits, including infection prevention, protection of at-risk skin, improved patient outcomes, and reduced total cost of care. ConvaTec has over 9,000 employees, with 11 manufacturing sites in 8 countries, and does business in more than 100 countries. ConvaTec is owned by Nordic Capital and Avista Capital Partners.
®/™ indicates trademarks of Unomedical a/s.
© 2015 ConvaTec Inc.
- Hudson E. & Murahata R.I. (2005) The ‘no-touch’ method of intermittent urinary catheter insertion: can it reduce the risk of bacteria entering the bladder? Spinal Cord 43(10), 611-614.
- Charbonneau-Smith R. (1993) No-touch catherterization and infection rates in a select spinal cord injured population. Rehabilitation Nursing 18(5), 296-299, 305.
- Newman D.K. & Willson M.M. (2011) Review of intermittent catheterization and current best practices. Urological Nursing 2011 Jan-Feb
- Hooton T.M. et al (2010) Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults. 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America.
- Bennett C.J. et al (1997) The effect of urethral introducer tip catheters on the incidence of urinary tract infection outcomes in spinal cord injured patients. The Journal of Urology 1997 Aug;158(2):519-21.